AAAAAA
Results: 1-25/35
Authors:
Cozzi, PJ
Malhotra, S
Mcauliffe, P
Kooby, DA
Federoff, HJ
Huryk, B
Johnson, P
Scardino, PT
Heston, WDW
Fong, Y
Citation: Pj. Cozzi et al., Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model, FASEB J, 15(7), 2001, pp. 1306-1308
Authors:
Potters, L
Kattan, MW
Scardino, PT
Citation: L. Potters et al., Combined-modality staging for localized adenocarcinoma of the prostate - The D'Amico article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1065
Authors:
Strom, SS
Spitz, MR
Yamamura, Y
Babaian, RJ
Scardino, PT
Wei, QY
Citation: Ss. Strom et al., Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: A case-control study, PROSTATE, 47(4), 2001, pp. 269-275
Authors:
Chang, S
Hursting, SD
Contois, JH
Strom, SS
Yamamura, Y
Babaian, RJ
Troncoso, P
Scardino, PT
Wheeler, TM
Amos, CI
Spitz, MR
Citation: S. Chang et al., Leptin and prostate cancer, PROSTATE, 46(1), 2001, pp. 62-67
Authors:
Herman, CM
Kattan, MW
Ohori, M
Scardino, PT
Wheeler, TM
Citation: Cm. Herman et al., Primary gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer - A multivariate analysis of 823 men treated with radical prostatectomy, AM J SURG P, 25(5), 2001, pp. 657-660
Authors:
Kothari, PS
Scardino, PT
Ohori, M
Kattan, MW
Wheeler, TM
Citation: Ps. Kothari et al., Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer, AM J SURG P, 25(11), 2001, pp. 1429-1432
Authors:
Kattan, MW
Potters, L
Blasko, JC
Beyer, DC
Fearn, P
Cavanagh, W
Leibel, S
Scardino, PT
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer, UROLOGY, 58(3), 2001, pp. 393-399
Authors:
Scardino, PT
Kim, ED
Citation: Pt. Scardino et Ed. Kim, Rationale for and results of nerve grafting during radical prostatectomy, UROLOGY, 57(6), 2001, pp. 1016-1019
Authors:
Lee, CT
Scardino, PT
Citation: Ct. Lee et Pt. Scardino, Percent free prostate-specific antigen for first-time prostate biopsy, UROLOGY, 57(4), 2001, pp. 594-598
Authors:
Kim, ED
Scardino, PT
Kadmon, D
Slawin, K
Nath, RK
Citation: Ed. Kim et al., Interposition sural nerve crafting during radical retropubic prostatectomy, UROLOGY, 57(2), 2001, pp. 211-216
Authors:
Maru, N
Ohori, M
Kattan, MW
Scardino, PT
Wheeler, TM
Citation: N. Maru et al., Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens, HUMAN PATH, 32(8), 2001, pp. 828-833
Authors:
Kim, ED
Nath, R
Kadmon, D
Lipshultz, LI
Miles, BJ
Slawin, KM
Tang, HY
Wheeler, T
Scardino, PT
Citation: Ed. Kim et al., Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup, J UROL, 165(6), 2001, pp. 1950-1956
Authors:
Ross, PL
Scardino, PT
Kattan, MW
Citation: Pl. Ross et al., Catalog of prostate cancer nomograms, J UROL, 165(5), 2001, pp. 1562-1568
Authors:
Ross, PL
Scardino, PT
Kattan, MW
Citation: Pl. Ross et al., Catalog of prostate cancer nomograms - Reply, J UROL, 165(5), 2001, pp. 1568-1568
Authors:
Baker, LH
Bahnson, RR
Hanks, GE
Huben, RP
Kantoff, P
Kozlowski, JM
Kuettel, M
Lange, PH
Logothetis, C
Pow-Sang, JM
Roach, M
Sandler, H
Scardino, PT
Taylor, RJ
Urban, DA
Walsh, PC
Wilson, TG
Citation: Lh. Baker et al., NCCN Practice Guidelines for prostate cancer, ONCOLOGY-NY, 14(11A), 2000, pp. 111-119
Authors:
Kattan, MW
Zelefsky, MJ
Kupelian, PA
Scardino, PT
Fuks, Z
Leibel, SA
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer, J CL ONCOL, 18(19), 2000, pp. 3352-3359
Authors:
Herman, CM
Wilcox, GE
Kattan, MW
Scardino, PT
Wheeler, TM
Citation: Cm. Herman et al., Lymphovascular invasion as a predictor of disease progression in prostate cancer, AM J SURG P, 24(6), 2000, pp. 859-863
Authors:
Catalona, WJ
Southwick, PC
Slawin, KM
Partin, AW
Brawer, MK
Flanigan, RC
Patel, A
Richie, JP
Walsh, PC
Scardino, PT
Lange, PH
Gasior, GH
Loveland, KG
Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260
Authors:
Catalona, WJ
Partin, AW
Slawin, KM
Naughton, CK
Brawer, MK
Flanigan, RC
Richie, JP
Patel, A
Walsh, PC
Scardino, PT
Lange, PH
deKernion, JB
Southwick, PC
Loveland, KG
Parson, RE
Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376
Authors:
Rabbani, F
Stapleton, AMF
Kattan, MW
Wheeler, TM
Scardino, PT
Citation: F. Rabbani et al., Factors predicting recovery of erections after radical prostatectomy, J UROL, 164(6), 2000, pp. 1929-1934
Authors:
Blute, ML
Bergstralh, EJ
Partin, AW
Walsh, PC
Kattan, MW
Scardino, PT
Montie, JE
Pearson, JD
Slezak, JM
Zincke, H
Citation: Ml. Blute et al., Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer, J UROL, 164(5), 2000, pp. 1591-1595
Authors:
Shalev, M
Kadmon, D
Teh, BS
Butler, EB
Aguilar-Cordova, E
Thompson, TC
Herman, JR
Adler, HL
Scardino, PT
Miles, BJ
Citation: M. Shalev et al., Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer, J UROL, 163(6), 2000, pp. 1747-1750
Authors:
Spitz, MR
Strom, SS
Yamamura, Y
Troncoso, P
Babaian, RJ
Scardino, PT
Wheeler, T
Amos, CI
von Eschenbach, A
Citation: Mr. Spitz et al., Epidemiologic determinants of clinically relevant prostate cancer, INT J CANC, 89(3), 2000, pp. 259-264
Authors:
Herman, JR
Adler, HL
Aguilar-Cordova, E
Rojas-Martinez, A
Woo, S
Timme, TL
Wheeler, TM
Thompson, TC
Scardino, PT
Citation: Jr. Herman et al., In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial, HUM GENE TH, 10(7), 1999, pp. 1239-1249
Authors:
Kattan, MW
Wheeler, TM
Scardino, PT
Citation: Mw. Kattan et al., Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer, J CL ONCOL, 17(5), 1999, pp. 1499-1507